Japan· JP-1149001F2222
イブプロフェン
A ibuprofen product containing イブプロフェン, registered in Japan by 日医工岐阜工場, on the national reimbursement list. The same ATC class is registered in 10 of our 19 countries.
Checked against MHLW / PMDA (Japan) on
Informational only — not a medical device.
Where it is registered
Ibuprofen is registered in 10 of 19 countries.
Countries holding a registration under ATC C01EB16 (ibuprofen), each read from that country’s own register.
- This record: Japan, from MHLW / PMDA (Japan)
- 6 of them publish a price we can compare per daily dose
Ibuprofen · ATC C01EB16
10 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
The record
At a glance
MHLW / PMDA (Japan)- Active substance
- イブプロフェン
- Manufacturer
- 日医工岐阜工場
- Country
- Japan (JP)
- ATC code
- C01EB16
- ATC class
- Ibuprofen
- Defined daily dose
- 30 mg, P
- Reimbursed
- Yes
- Source register
- MHLW / PMDA (Japan)
- Last checked
- September 25, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
805 interactions on record for ibuprofen.
Graded by severity as the source publishes them — 71 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Ibuprofen · interactions on record
805 records
- 71 severe
- 306 moderate
- 15 minor
- 413 info
Most severe, free to view
- DicoumarolB01AA01severe
- WarfarinB01AA03severe
- DalteparinB01AB04severe
- EnoxaparinB01AB05severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under C01EB16
Ibuprofen, as other registers publish it.
- DenmarkIbuprofen Gen.OrphGen.Orph SaS
- IcelandIbuprofen Gen.OrphGen.Orph
- PolandIbuprofen Gen.OrphGen.Orph
- FinlandIbuprofen Gen.OrphGEN.ORPH
- CzechiaIBUPROFEN GEN.ORPHGen.Orph, Saint Cloud
- BelgiumIbuprofen Gen.Orph 5 mg/mlGen-Orph
- IrelandIbuprofen Gen.Orph 5 mg/mL solution for injectionGen.Orph
- NetherlandsIbuprofen Gen.Orph 5 mg/ml-oplossing voor injectieGen-Orph SaS
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of MHLW / PMDA (Japan). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/bd6764c6-5bec-432b-bb0e-179fabed8d0f GET /v1/drugs/bd6764c6-5bec-432b-bb0e-179fabed8d0f?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"spec": "２００ｍｇ１錠",
"marks": null,
"source": "mhlw",
"remarks": null,
"yj_code": "1149001F2222",
"category": "内用薬",
"price_yen": 8.9,
"generic_name": "イブプロフェン",
"product_name_jp": null,
"therapeutic_class": "1149",
"transitional_expiry": null
}See everything about ibuprofen.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.